If this message is not displayed correctly, click here.

No 119, December 2017

Prof. Mustafa Arici

Holiday Wishes from ERA-EDTA Flash Editor–in-Chief, Prof. Mustafa Arici


Dear valuable readers of ERA-EDTA Flash,

 

The end of the year is a good occasion to get ready for a ‘fresh’ start of the New Year to come!  The ERA-EDTA has always been coming up with ‘fresh’ ideas and new initiatives. In 2018 many changes will be put in place in ERA-EDTA Flash: the newsletter will be in fact circulated once a week!

Readers will have the chance to receive more news funnelled under four specific headings:  ‘education’, ‘research’, ‘association’ and ‘institutional’. ERA-EDTA Flash will also be instrumental for all updates related to the ERA-EDTA activities, Congresses, CME courses, hot papers from the ERA-EDTA Journals (namely NDT and CKJ) and the European Nephrology Portal (ENP).

Keep on following us and be an active partner of the ERA-EDTA by giving us your feedback. The Society can only continue to grow when receiving your valuable support.

 

I hope the New Year brings more peace to the World and serenity to everyone and everywhere. On behalf of the ERA-EDTA Flash Editorial team and the entire ERA-EDTA family, I would like to wish you a wonderful New Year filled with abundance, joy and treasured moments.

Image

Learn from Key Summaries

A series of new NDT-Educational Summary Reports of the 54th ERA-EDTA Congress and a review of the Astra Zeneca lunch symposium have recently been published on ENP:

·         Hyperkalaemia in CKD: An Evolving Treatment Landscape

·         Inflammation and innate immunity in CKD-associated vascular diseases

·         Metabolomics and/or Uremic Toxins

·         Update on endothelin and mineralocorticoid receptor antagonists

·         Diuretics in AKI - yes, no or maybe?

·         SGLT-2: role in physiology and pathophysiology

·         Hematuria in glomerular disease – is it important for the outcome of the patients?

·         Personalized monitoring and treatment in membranous nephropathy

·         Complement activation in IgA nephropathy, membranous nephropathy and FSGS

·         Starting hemodialysis - an incremental approach

Click here to access the Summary Reports of the 54th ERA-EDTA Congress and here for a review of the Astra Zeneca symposium ‘Hyperkalaemia in CKD: An Evolving Treatment Landscape’.

Image
NDT and CKJ articles

Just published online: read the latest NDT and CKJ articles

Elevated serum uric acid was associated with all-cause mortality in CKD patients

A study published in NDT evaluated the association between serum uric acid (SUA) and outcome in CKD patients. The authors conducted this prospective cohort study from a Taiwanese 13-year multidisciplinary pre-ESRD care registry. More than 5,000 patients were analysed. They evaluated the prospective relationship between SUA trajectories and the risk of dialysis and all-cause mortality – and found significant correlations.

According to the authors, these findings demonstrate the need to evaluate the longitudinal effectiveness of urate-lowering substances in reducing the risk of mortality and in slowing down progression to ESRD in CKD patients. There is an urgent need to assess, whether SUA is an independent therapy target or just a “co-factor” without any clinical relevance. As the study authors pointed out, there is a further need to determine the time and the means by which to optimize SUA

A wide gap between attitudes and reality? Attitudes towards assisted home dialysis in Germany

Dr Pommer and colleagues conducted a survey to explore the current practice of assisted home dialysis (AHD) in Germany, nephrologists´ attitudes and presumed barriers for implementing AHD in routine dialysis care. A total of 286 nephrologists (14% of the 2,060 contacted nephrologists) answered the survey. The results have now been published in CKJ.

In view of the respondents, AHD should be offered to all patients complaining of the high burden of home dialysis (22%), at the request of the patient (33%) as well as to all home-treated patients with impaired capabilities (75%). 96% of the respondents believed that AHD is meaningful. But in contrast to this belief, only a small percentage of ESRD patients (only about 5%) in Germany is treated with home dialysis – obviously there is a wide gap between attitudes and reality. The authors suggest that this might be the result of a reporting bias. The nephrologists who took part in the survey are obviously those who supported and implemented AHD, while the great majority, who does not support AHD, did not participate in the survey. Barriers of AHD named by the respondents were reimbursement problems, lack of expertise and lack of motivation.

Who are the ERA-EDTA members?

With more than 7,500 members, the ERA-EDTA is one of the biggest nephrology associations worldwide and one of the most important and prestigious European Medical Associations. Its members’ interests cover a wide spectrum of fields: from Clinical Nephrology to Basic science, from Dialysis to Immunology, from CKD to renal Transplantation, Cardiovascular Diseases and Diabetes.

An infographic was created (using data collected by the ERA-EDTA Membership Office) to visually present information and statistics related to the ERA-EDTA members.

 

Click here to have a look at it.

ERA-EDTA: Innovation and Education in Kidney Science and Care.
Web Site
 
secretariat@era-edta.org
 
 
Facebook
 
Twitter
 
Google+
 
LinkedIn
 
Instagram
 
YouTube
 
Vimeo
 

ERA-EDTA Flash is the official ERA-EDTA eNewsletter

Editor-in-Chief: Mustafa Arici
Editorial Secretariat: Valentina Cocchi
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters
Via XXIV Maggio, 38
43123 Parma - Italy

The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003.